SP
JNJ icon

Saranac Partners’s Johnson & Johnson JNJ Stock Holding History

Saranac Partners’s Portfolio JNJ Stock Details JNJ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$409K Sell
1,612
-14,020
-90% -$3.27M 0.12% 85
2026
Q1 		$686K Buy
15,632
+13,995
+855% +$3.26M 0.29% 53
2025
Q4 		$339K Buy
1,637
+155
+10% +$30.7K 0.13% 61
2025
Q3 		$275K Buy
1,482
+110
+8% +$18.8K 0.05% 178
2025
Q2 		$210K Buy
+1,372
New +$211K 0.11% 66
2023
Q4 		– Sell
-1,376
Closed -$214K – 88
2023
Q3 		$214K Hold
1,376
– – 0.12% 73
2023
Q2 		$228K Hold
1,376
– – 0.12% 77
2023
Q1 		$213K Buy
+1,376
New +$222K 0.13% 78

Other funds holding JNJ

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $146B AUM 55.73% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Saranac Partners's JNJ Position: Q2 2026 in Review

Saranac Partners reduced its Johnson & Johnson (JNJ) stake by 90% in Q2 2026, selling an estimated $3.27M and leaving 1,612 shares worth $409K. The position accounts for 0.12% of the portfolio, ranked #85.

Saranac Partners first reported a position in JNJ in Q1 2023 and has held it in 8 quarters since. The position peaked at $686K in Q1 2026. 4,698 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Saranac Partners held 1,612 shares of Johnson & Johnson worth $409K as of Q2 2026.
  • Saranac Partners sold 14,020 Johnson & Johnson shares in Q2 2026, an estimated $3.27M.
  • Johnson & Johnson made up 0.12% of Saranac Partners's portfolio in Q2 2026, its #85 holding.
  • Saranac Partners first reported a position in Johnson & Johnson in Q1 2023 and has held it in 8 quarters since.
  • Saranac Partners's Johnson & Johnson position peaked at $686K in Q1 2026.
  • 4,698 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Saranac Partners's 13F filing for Q2 2026, filed 13 Aug 2026.